aEli Lilly and Company, Windlesham, Surrey, UK; bSydney Childrens Hospital,, Randwick, New South Wales, Australia; cEli Lilly and Company, Indianapolis, Indiana, USA; dThomas Jefferson University, Philadelphia, Pennsylvania, USA; eUniversity of Montreal and CHU Ste-Justine, Montreal, Quebec, Canada; fErasmus Medical Centre Sophia, Rotterdam, The Netherlands; gUniversity of Giessen, Giessen, Germany
aHôpital Necker Enfants Malades, AP-HP, Université Paris Descartes, Paris, France; bChildrens Hospital, University of Bonn, Bonn, Germany; cFaculty of Health Sciences, Linköping University, Linköping, Sweden; dIPSEN Pharma, Boulogne Billancourt, France
aPROLOR Biotech, Nes Ziona, Israel; bKaplan Medical Center, Rechovot, Israel; c2nd Children City Clinic, Minsk, Belarus; dUkrainian Children Specialized Clinical Hospital, Kyev, Ukraine; eBashkir State Medical University, Ufa, Russia; fUMHAT Sv. Marina, Varna, Bulgaria; gSt. Petersburg State Pediatric Medical Academy, St Petersburg, Russia
aDépartement de Pédiatrie, Université Claude Bernard, Lyon, France; bManchester Academic Health Sciences Centre, Royal Manchester Childrens Hospital, Manchester, UK; cQuartz Bio, Geneva, Switzerland
aDivision of Pediatric Endocrinology, 3rd Department of Pediatrics, Attikon Univeristy Hospital, Athens, Greece; bDivision of Pediatric Endocrinology, Athens Medical Center, Athens, Greece
aDepartment of Medical and Surgical Sciences of the Mother, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy; bDepartment of Clinical and Experimental Medicine and Surgery 2, Chair of Endocrinology, Second University of Naples, Naples, Italy
aMaternal and Infant Department, St Chiara University Hospital of Pisa, Pisa, Italy; bPediatric Unit, ASL2 Lucca Hospital, Lucca, Italy; cEpidemiology Unit, Department of Experimental Pathology M.B.I.E., University of Pisa, Pisa, Italy